Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mira Harrison-Woolrych

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|March 18, 2006
Who will fund hypothesis testing studies?Mira Harrison-Woolrych
BMJ (Clinical Research Ed.)|November 10, 2012
Varenicline for smoking cessationMira Harrison-Woolrych
Contraception|January 15, 2004
Ectopic pregnancies following emergency levonorgestrel contraceptionMira Harrison-Woolrych
BMJ (Clinical Research Ed.)|January 2, 2010
Varenicline and suicide. Safety data from New ZealandMira Harrison-Woolrych
Drug Safety|October 11, 2011
Patient reporting encouraged during monitoring of dapoxetine in New ZealandMira Harrison-Woolrych
Drug Safety|January 16, 2020
A New President's Vision for International PharmacovigilanceMira Harrison-Woolrych
Drug Safety|September 8, 2022
How Important is Gender in Leadership in Pharmacovigilance? Personal Reflections from the First Female President of the International Society of PharmacovigilanceMira Harrison-Woolrych
BMJ (Clinical Research Ed.)|March 19, 2015
Mental health effects of vareniclineMira Harrison-Woolrych
Drug Safety|August 12, 2011
Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New ZealandMira Harrison-Woolrych, Janelle Ashton
BMJ Sexual & Reproductive Health|July 28, 2022
The immediate post-Roe landscapeSam Rowlands, Mira Harrison-Woolrych
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|March 18, 2006
Who will fund hypothesis testing studies?Mira Harrison-Woolrych
BMJ (Clinical Research Ed.)|November 10, 2012
Varenicline for smoking cessationMira Harrison-Woolrych
Contraception|January 15, 2004
Ectopic pregnancies following emergency levonorgestrel contraceptionMira Harrison-Woolrych
BMJ (Clinical Research Ed.)|January 2, 2010
Varenicline and suicide. Safety data from New ZealandMira Harrison-Woolrych
Drug Safety|October 11, 2011
Patient reporting encouraged during monitoring of dapoxetine in New ZealandMira Harrison-Woolrych
Drug Safety|January 16, 2020
A New President's Vision for International PharmacovigilanceMira Harrison-Woolrych
Drug Safety|September 8, 2022
How Important is Gender in Leadership in Pharmacovigilance? Personal Reflections from the First Female President of the International Society of PharmacovigilanceMira Harrison-Woolrych
BMJ (Clinical Research Ed.)|March 19, 2015
Mental health effects of vareniclineMira Harrison-Woolrych
Drug Safety|August 12, 2011
Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New ZealandMira Harrison-Woolrych, Janelle Ashton
BMJ Sexual & Reproductive Health|July 28, 2022
The immediate post-Roe landscapeSam Rowlands, Mira Harrison-Woolrych
Pageof 5